Abstract
Catecholaminergic signaling regulates various physiological functions, such as blood pressure1 and is implicated in drug dependence, affective disorders and male aggressive behavior2,3. The actions of released catecholamines are terminated by sodium-driven, high-affinity transporters in the plasma membrane of the releasing neurons4,5 and by a corticosterone-sensitive, low-affinity, high-capacity extraneuronal transport system6, originally named uptake2, found in sympathetically innervated tissues7 and in central nervous system glia8. Here we report the molecular identification and pharmacological characterization of the extraneuronal catecholamine transporter, which is unrelated to the family of sodium-driven neuronal monoamine transporters5.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.